Shilpa Medicare Limited (BSE: 530549)
Health Care · Pharmaceuticals · IN
Rs937.50
-8.12% today · +163.2% 1Y
Shilpa Medicare Limited (BSE: 530549) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.93B.
Over the last twelve months the share price has gained 163.2%, trading between 260.00 and 1.10K.
Tweenvest scores Shilpa Medicare Limited across four factors: quality 73/100, value 29/100, growth 76/100, dividend 40/100. Its strongest factor is growth.
530549 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.93B
- Revenue (TTM)
- $178.02M
- P/E
- 61.69
- EPS
- 15.20
- Dividend yield
- 0.06%
- Beta (5Y)
- 0.35
- 52-week high
- Rs1,095.65
- 52-week low
- Rs260.00
- Avg volume (3M)
- —
- Shares outstanding
- 195.58M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BrightGene Bio-Medical Technology Co., Ltd.SHSE: 688166 | $2.01B | CN¥30.91 | -7.81% |
| Fujian Cosunter Pharmaceutical Co., Ltd.SZSE: 300436 | $2.01B | CN¥80.00 | -1.80% |
| Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.SHSE: 603707 | $1.97B | CN¥8.15 | -0.37% |
| Pharvaris N.V.NasdaqGS: PHVS | $1.95B | $27.74 | -10.80% |
| Trulieve Cannabis Corp.NYSE: TRLV | $1.93B | $10.01 | -2.82% |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | $1.90B | CN¥10.96 | -8.21% |
| Xeris Biopharma Holdings, Inc.NasdaqGS: XERS | $1.88B | $10.33 | +2.58% |
| Cohance Lifesciences LimitedNSEI: COHANCE | $1.87B | Rs464.05 | +5.23% |
Figures last refreshed Oct 11, 2026.